These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 2587586)

  • 1. Binding of human C3a and the synthetic nonapeptide C3a (tyr-70-77) to rat peritoneal mast cells.
    Gervasoni JE; Ruddy S
    Prog Clin Biol Res; 1989; 297():221-31; discussion 231-2. PubMed ID: 2587586
    [No Abstract]   [Full Text] [Related]  

  • 2. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan.
    Gervasoni JE; Conrad DH; Hugli TE; Schwartz LB; Ruddy S
    J Immunol; 1986 Jan; 136(1):285-92. PubMed ID: 3510005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control.
    Fukuoka Y; Hugli TE
    J Immunol; 1990 Sep; 145(6):1851-8. PubMed ID: 1697312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies and inhibitor of chymase are incorporated into mast cell granules and inhibit histamine release.
    Kido H; Fukusen N; Katunuma N
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():95-100. PubMed ID: 2462436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of C3a and C5a in the activation of mast cells.
    Erdei A; Kerekes K; Pecht I
    Exp Clin Immunogenet; 1997; 14(1):16-8. PubMed ID: 9187918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic analysis of mast cell granule proteinases in normal rat bone marrow cultures.
    McMenamin C; Haig DM; Gibson S; Newlands GF; Miller HR
    Immunology; 1987 Jan; 60(1):147-9. PubMed ID: 3546099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for in vivo degradation of C3a anaphylatoxin by mast cell chymase. I. Nonspecific activation of rat peritoneal mast cells by C3ades Arg.
    Kajita T; Hugli TE
    Am J Pathol; 1991 Jun; 138(6):1359-69. PubMed ID: 2053593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical characterisation of the myofibrillar proteinase from cultured rat myocytes as chymase.
    Heath R; Kay J; Kuehn L; Dahlmann B; Stauber WT; Mayer M
    Biochem Int; 1987 Apr; 14(4):675-83. PubMed ID: 3330939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro translation of mRNA from rat peritoneal and intestinal mucosal mast cells.
    Imai T; Fujimaki H; Abe T; Befus D
    Int Arch Allergy Immunol; 1993; 102(1):26-32. PubMed ID: 7691295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat serosal mast cell degranulation mediated by chymase, an endogenous secretory granule protease: active site-dependent initiation at 1 degree C.
    Schick B; Austen KF
    J Immunol; 1986 May; 136(10):3812-8. PubMed ID: 2939135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of mast-cell-specific proteases in tissues of mice studied by in situ hybridization.
    Jippo T; Tsujino K; Kim HM; Kim DK; Lee YM; Nawa Y; Kitamura Y
    Am J Pathol; 1997 Apr; 150(4):1373-82. PubMed ID: 9094993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to C3a, mast cells, and asthma.
    Zaidi AK; Amrani Y; Panettieri RA; Ali H
    FASEB J; 2006 Feb; 20(2):199. PubMed ID: 16449789
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
    Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
    J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular chymase: pathophysiological role and therapeutic potential of inhibition.
    Doggrell SA; Wanstall JC
    Cardiovasc Res; 2004 Mar; 61(4):653-62. PubMed ID: 14985062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective conversion of big endothelins to tracheal smooth muscle-constricting 31-amino acid-length endothelins by chymase from human mast cells.
    Nakano A; Kishi F; Minami K; Wakabayashi H; Nakaya Y; Kido H
    J Immunol; 1997 Aug; 159(4):1987-92. PubMed ID: 9257865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of tryptase inhibitors on histamine release from human colon mast cells].
    Xie H; He SH; Cheng MH; Fu YL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):678-81. PubMed ID: 15555433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent and selective inhibition of membrane-type serine protease 1 by human single-chain antibodies.
    Sun J; Pons J; Craik CS
    Biochemistry; 2003 Feb; 42(4):892-900. PubMed ID: 12549907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils.
    Matsunaga Y; Kido H; Kawaji K; Kamoshita K; Katunuma N; Ogura T
    Arch Biochem Biophys; 1994 Jul; 312(1):67-74. PubMed ID: 8031148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adriamycin induces exocytosis in rat and beige mouse peritoneal mast cells: an ultrastructural, morphometric and biochemical study.
    Crivellato E; Candussio L; Decorti G; Klugmann FB; Mallardi F
    J Submicrosc Cytol Pathol; 1999 Apr; 31(2):279-86. PubMed ID: 10457614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
    Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
    J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.